Direct modulation of Ca(2+)-activated K(+) current by H-89 in rabbit coronary arterial smooth muscle cells

Vascul Pharmacol. 2007 Feb;46(2):105-13. doi: 10.1016/j.vph.2006.08.413. Epub 2006 Sep 8.

Abstract

The effects of H-89, a potent and selective inhibitor of protein kinase A (PKA) on Ca(2+)-activated K(+) (BK(Ca)) channels in coronary arterial smooth muscle cells were examined using a patch-clamp technique. In inside-out configuration, H-89 increased the NP(o) of the BK(Ca) channel, but it reduced the dwell time of BK(Ca) currents. In whole-cell configuration, H-89 markedly increased BK(Ca) currents in a concentration-dependent manner. The EC(50) was 0.470+/-0.0741 microM based on dwell time, 0.582+/-0.0691 microM based on the NP(o), and 0.519+/-0.0295 microM based on the whole-cell current, respectively. H-85, which is an inactive form of H-89, increased BK(Ca) currents, similar to the result of H-89. The other PKA inhibitors (Rp-8-CPT-cAMPs and KT 5720) and protein phosphatase inhibitor (okadaic acid, 1 microM) had little effect on BK(Ca) currents and did not significantly alter the stimulatory effects of 1 microM H-89. These findings suggest that H-89 increases the BK(Ca) current independently of PKA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbazoles / pharmacology
  • Coronary Circulation / drug effects
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Indoles / pharmacology
  • Isoquinolines / pharmacology*
  • Membrane Potentials / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Okadaic Acid / pharmacology
  • Patch-Clamp Techniques
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Potassium Channels, Calcium-Activated / drug effects*
  • Potassium Channels, Calcium-Activated / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrroles / pharmacology
  • Rabbits
  • Sulfonamides / pharmacology*
  • Thionucleotides / pharmacology
  • Time Factors
  • Vascular Resistance / drug effects

Substances

  • Carbazoles
  • Enzyme Inhibitors
  • Indoles
  • Isoquinolines
  • Potassium Channels, Calcium-Activated
  • Protein Kinase Inhibitors
  • Pyrroles
  • Sulfonamides
  • Thionucleotides
  • Okadaic Acid
  • 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP
  • KT 5720
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Phosphoprotein Phosphatases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide